We are international
• treatment options TEXT SIZE   
bone disease    back

Bisphosphonate Therapy

11.21.11   Understanding Bisphosphonate Therapy

This booklet is devoted to therapy that is given to patients with myeloma bone involvement. Approximately 80% of myeloma patients develop bone disease. Bisphosphonates help to prevent skeletal complications of myeloma. Treatment with bisphosphonates reduces bone damage and, when the myeloma is well controlled, allows bone healing to occur. 

11.21.11   IMWG Guidelines for the Use of Bisphosphonates in Myeloma

11.21.11   International Myeloma Workshop 2011
Dr. Gimsing - Bisphosphonates: Can the Dose be Lowered?
Peter Gimsing, MD
Rigshospitalet, Copenhagen University
Copenhagen, Denmark
May 3-6, 2011
Paris, France

11.21.11   Use of Bisphosphonates in Multiple Myeloma: IMWG Response to Mayo Clinic Consensus Statement

06.21.11   Aredia/Zometa and osteonecrosis of the jaws

04.04.11   Salvatore L. Ruggiero, DMD, MD Talks About Osteonecrosis of the Jaw (ONJ)

11.21.11   Osteonecrosis of the Jaw and Bisphosphonates

04.18.04   Bisphosphonates For Myeloma - Current Approach To Treatment
An overview by IMF Scientific Advisor Phil Greipp

04.18.04   Bone Metabolism, Bone Disease, and the Bisphosphonates
An excellent overview by IMF Scientific Advisor Greg Mundy and Babatunde O. Oyajobi, MB, ChB, PhD

03.26.05   HealthTalk Bone Disease Webcast
IMFer Mike Katz and Dr. Paul Richardson discuss myeloma bone disease